Experts in particle engineering

Hovione Technology relies in Hovione’s expertise in development and manufacturing of highly sophisticated inhalation API’s.
Hovione uses cutting-edge particle engineering technologies suitable for developing new inhalation products or matching innovators.

Hovione can tailor-make particle size distributions through complex particle engineering technologies – like jet milling, wet-polishing, microencapsulation, monosep, nanomilling and others –  in ranges suitable for inhalation and incorporate desired morphology characteristics into the API. 

Hovione’s capabilities include fine tuning of the particle size distribution of the API with unprecedent control, exceeding by far what can typically be achieved by traditional technologies. Hovione allows partners to target challenging DV50 and very tight spans with great consistency from batch to batch. The reduction in variability of API particle size distribution simplifies the formulation development effort.

Hovione inhalation grade APIs are different at the particle level. They have very little or no amorphous content and the particles are smooth with no sharp edges. The former translates into reduced particle to particle bridging which improves API and formulation stability. The later leads to more predictable particle cohesion properties in the formulation.

Hovione is also able to start with a Hovione-produced API and develop a dry powder formulation to meet the customer’s inhalation product development demands.

The cutting-edge particle engineering technologies suitable for inhalation coupled with hands-on inhaler development knowledge allows Hovione to deliver high quality results for the partners' inhalation drug development programs, ranging from developing new products for inhalation to matching innovator in-vitro deposition profiles.


Contact us for more information
Cookie Policy
This site uses cookies. When browsing the site, you are consenting its use.
Learn more
I understood